Insmed Inc’s recent filing unveils that its Director ANDERSON ELIZABETH M unloaded Company’s shares for reported $1.02 million on Nov 24 ’25. In the deal valued at $204.58 per share,5,000 shares were sold. As a result of this transaction, ANDERSON ELIZABETH M now holds 58,729 shares worth roughly $12.2 million.
Then, ANDERSON ELIZABETH M bought 5,000 shares, generating $1,020,000 in total proceeds.
Before that, LEE LEO sold 75,000 shares. Insmed Inc shares valued at $14,692,249 were divested by the Director at a price of $195.90 per share. As a result of the transaction, LEE LEO now holds 54,677 shares, worth roughly $11.36 million.
A number of analysts have revised their coverage, including Wells Fargo’s analysts, who began to cover the stock in mid October with a ‘”an Overweight”‘ rating. William Blair began covering INSM with “an Outperform” recommendation on August 20, 2025. Morgan Stanley revised its rating on August 13, 2025. It rated INSM as “an Equal-weight” which previously was an “an Overweight”.
Price Performance Review of INSM
On Friday, Insmed Inc [NASDAQ:INSM] saw its stock jump 1.59% to $207.77. Over the last five days, the stock has gained 4.07%. Insmed Inc shares have risen nearly 180.43% since the year began. Nevertheless, the stocks have risen 200.94% over the past one year. While a 52-week high of $209.77 was reached on 11/25/25, a 52-week low of $60.40 was recorded on 04/09/25.
Levels Of Support And Resistance For INSM Stock
The 24-hour chart illustrates a support level at 204.42, which if violated will result in even more drops to 201.06. On the upside, there is a resistance level at 209.59. A further resistance level may holdings at 211.40.
How much short interest is there in Insmed Inc?
A steep rise in short interest was recorded in Insmed Inc stocks on 2025-11-14, dropping by -0.55 million shares to a total of 8.93 million shares. Yahoo Finance data shows the prior-month short interest on 2025-10-15 was 9.48 million shares. There was a decline of -6.21%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on May 13, 2025 when Jefferies began covering the stock and recommended ‘”a Buy”‘ rating along with a $105 price target.
